The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Understanding Your LabsUnderstanding Your Labs
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

CD4 count progreesion

Dec 20, 2009

Hello Dr, I started ARV's( Truvada + Stocrin) a year ago when I was tested and found to be positive( CD4 was 185 and VL was approx 10000 )My recent results a year later are CD4 = 340 and VL undetectable( VL been undecrtable for 9 months sofar) . My questions are thus: What is the normal rate at which CD4 count should rise if VL remains undetectable and will the fact that I started ARV's which such a low CD4 count have any bearing on my prognosis. Thanks in advance

Response from Dr. Holodniy

Since we usually don't know what someone's baseline CD4 count was before HIV infection, it is always difficult to predict how far and over what time frame the CD4 count will increase. On average, the CD4 count will increase by about 150 after starting HIV treatment depending on where the CD4 count was before starting treatment. The CD4 count can continue to increase slowly thereafter, even over several years.

atripla and high AST and ALT levels
Significance of CD8/CD8% declining

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint